A posterior chamber
intraocular lens (PCIOL) was implanted in the capsular bag.
After preoperative recordings, the subjects underwent successful phacoemulsification surgery and posterior chamber
Pupillary dilation was required only in cases where it was combined with cataract extraction with posterior chamber
intraocular lens (PCIOL) implantation or scleral fixated IOL.
The patient underwent pars plana anterior vitrectomy, dislocated IOL explantation through corneal incision, and fixation of 3-piece posterior chamber
IOL (Alcon Acrysof MA60AC, Alcon Laboratories, USA) to iris under general anesthesia.
An intraocular lens was implanted in the posterior chamber
by scleral fixation (Figure 4).
Drug related adverse events were all expected and included anterior chamber inflammation, posterior chamber
inflammation and increase in intraocular pressure, but all were manageable with standard-of-care treatments and resolved without clinical sequelae.
Retrospective comparison of techniques to prevent secondary cataract formation after posterior chamber
intraocular lens implantation in infants and children.
Phacoemulsification with posterior chamber
intra ocular lens (PC IOL) implantation is a frequently performed surgical procedure for cataract and posterior capsular opacification (PCO) also known as after cataract is a most common late post-surgical complication1 with PC IOL implantation having an incidence of 20% to 40% five years postoperatively2 in adults and up to 100% in pediatric patients3.
Breakdown of this barrier can be seen in numerous inflammatory and infective disorders where large proteins Teak' through into the anterior chamber causing it to become cloudier and 'plasma-like.' The non-pigmented epithelium actively transports ions into the posterior chamber
, which then allows for the passive flow of water and the formation of aqueous humour.
intraocular lenses: long-term results in pediatric cataract patients.
The trial evaluated the safety and efficacy of trans-scleral iontophoretically-delivered EGP-437, dexamethasone, through the Company's EyeGate II Delivery System in patients that have previously undergone cataract surgery with implantation of a monofocal posterior chamber
IOL, starting immediately after surgery.
ECCE with posterior chamber
intraocular lens (IOL) implantation is the primary surgical choice than intracapsular cataract extraction for the treatment of cataract.